Key Points
- CEO Jason Hulse Murray sold 8,771 PACS shares at an average price of $45.16, generating $396,098.36. The sale was made under a pre-arranged Rule 10b5-1 plan and reduced his ownership by just 0.02%.
- Murray has made multiple additional sales in recent weeks, while still directly holding approximately 54.6 million shares valued at about $2.46 billion.
- PACS reported quarterly EPS of $0.63, beating estimates of $0.54, and revenue of $1.43 billion. Analysts maintain a “Moderate Buy” consensus with an average price target of $58.80, compared with shares opening at $44.61.
PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 317 shares of the firm's stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51. Following the completion of the sale, the chief executive officer owned 54,555,249 shares in the company, valued at approximately $2,456,622,862.47. The trade was a 0.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total transaction of $476,226.67.
- On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total transaction of $396,098.36.
- On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The shares were sold at an average price of $43.33, for a total transaction of $206,164.14.
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total transaction of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total transaction of $984,943.68.
- On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The stock was sold at an average price of $42.56, for a total transaction of $858,562.88.
- On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total transaction of $1,021,242.02.
- On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The shares were sold at an average price of $42.39, for a total value of $1,024,015.23.
- On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total value of $2,600,811.60.
- On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The stock was sold at an average price of $43.92, for a total value of $4,010,159.52.
PACS Group Price Performance
PACS Group stock opened at $44.61 on Tuesday. The stock has a 50-day moving average price of $44.74 and a two-hundred day moving average price of $39.12. PACS Group, Inc. has a 12 month low of $9.69 and a 12 month high of $49.49. The company has a market capitalization of $7.06 billion, a PE ratio of 25.93, a P/E/G ratio of 1.40 and a beta of -0.13. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.
PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. Analysts expect that PACS Group, Inc. will post 2.13 EPS for the current year.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on PACS. Truist Financial set a $62.00 price objective on shares of PACS Group in a research note on Wednesday, September 2nd. Oppenheimer raised their target price on PACS Group from $48.00 to $57.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. UBS Group upped their price target on PACS Group from $57.00 to $60.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Weiss Ratings cut PACS Group from a "hold (c+)" rating to a "hold (c)" rating in a research note on Wednesday, August 5th. Finally, JPMorgan Chase & Co. raised their price objective on PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a research report on Friday, September 4th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $58.80.
Check Out Our Latest Stock Analysis on PACS Group
Hedge Funds Weigh In On PACS Group
A number of hedge funds have recently bought and sold shares of PACS. Tidal Investments LLC acquired a new position in PACS Group in the second quarter valued at $252,000. Engineers Gate Manager LP acquired a new stake in PACS Group during the 2nd quarter worth about $1,132,000. Integrated Wealth Concepts LLC bought a new position in shares of PACS Group in the 2nd quarter worth about $75,000. Squarepoint Ops LLC raised its position in shares of PACS Group by 94.7% in the 2nd quarter. Squarepoint Ops LLC now owns 59,523 shares of the company's stock worth $2,538,000 after acquiring an additional 28,945 shares in the last quarter. Finally, Nykredit A S acquired a new position in shares of PACS Group in the 2nd quarter valued at about $95,000.
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.
The company's broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
